Sprites
Mein FinanzNachrichtenJetzt AnmeldenPasswort vergessen?
Montag, 28.05.2012Börsentäglich über 11.000 News von 416 internationalen Medien
Erweiterte
Suche
Ad hoc-Mitteilungen

ALEXION PHARMACEUTICALS INC

WKN: 899527  ISIN: US0153511094  Ticker-Symbol: AXP 
Aktie:
Branche
Pharma
Aktienmarkt
NASDAQ-100
S&P 500
NASDAQ Biotech
1-Jahres-Chart
ALEXION PHARMACEUTICALS INC Chart 1 Jahr
1-Woche-Intraday-Chart
ALEXION PHARMACEUTICALS INC 1-Woche-Intraday-Chart

Aktuelle News zur ALEXION PHARMACEUTICALS Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache:
LeserMedien
24.05. 41
HONG KONG -- (Marketwire) -- 05/24/12 -- Today, www.BrightonMarkets.com announced new reports highlighting Priceline.com Inc (NASDAQ: PCLN) and Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN). Gain market...
Mehr lesen zu:
Today's Economic Outlook - Report Highlights Priceline.com Inc and Alexion Pharmaceuticals, Inc.
22.05. 13
22.05. 5
21.05. 12
21.05. 7
21.05. 37
17.05. 7
15.05. 3
12.05. 6
10.05. 47
Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced that Dr. Leonard Bell, Chief Executive Officer of Alexion Pharmaceuticals, will present at the Bank of America...
Mehr lesen zu:
Alexion to Present at Bank of America Merrill Lynch 2012 Health Care Conference
10.05. 5
08.05. 32
07.05. 25
02.05. 9
30.04. 38
Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced that Vikas Sinha, Chief Financial Officer of Alexion Pharmaceuticals, will present at the Deutsche Bank Securities...
Mehr lesen zu:
Alexion to Present at Deutsche Bank Securities 37th Annual Health Care Conference
25.04. 5
24.04. 12
24.04. 67
WASHINGTON (dpa-AFX) - Alexion Pharmaceuticals, Inc. (ALXN) posted first-quarter net income of $45.4 million or $0.23 per share versus $26.8 million or $0.14 per share last year. Non-GAAP...
Mehr lesen zu:
Alexion Q1 Profit Rises
24.04. 44
– Soliris® (eculizumab) Net Product Sales Increased 47 Percent OverYear-Ago Quarter to $244.7 Million – – Continued Steady Growth in PNH –– aHUS Launch Progresses...
Mehr lesen zu:
Alexion Reports First Quarter 2012 Results
19.04. 35
CHICAGO, April 19, 2012 /PRNewswire/ --Zacks Equity Research highlights: Alexion Pharmaceuticals(Nasdaq: ALXN) as the Bull of the Day and CSN(NYSE: SID) as the Bear of the Day. In addition, Zacks...
Mehr lesen zu:
Zacks Bull and Bear of the Day Highlights: Alexion Pharmaceuticals, CSN, CBS, News Corporation and Comcast
Seite: 1 2 3 Weiter>>
56 Nachrichten in den letzten 6 Monaten